Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$124.05
pos +0.00
+0.00%
Today's Range: 123.20 - 124.33 | CELG Avg Daily Volume: 3,649,700
Last Update: 04/28/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 7.17%
Open: $0.00
Previous Close: $123.97
52 Week Range: $94.42 - $127.64
Oustanding Shares: 777,966,471
Market Cap: 96,444,503,410
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 15 15 15 15
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.24 1.24 1.24 1.24
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 46.61
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
46.61 49.80 29.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.18% 14.83% 73.78%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.30 0.70 0.20
Net Income 24.80 0.40 0.11
EPS 28.40 0.50 0.14
Earnings for CELG:
EBITDA 3.71B
Revenue 11.23B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.60 $1.71 $6.61 $8.20
Number of Analysts 5 5 5 4
High Estimate $1.64 $1.77 $6.68 $8.45
Low Estimate $1.54 $1.67 $6.51 $7.82
Prior Year $1.28 $1.39 $5.18 $6.61
Growth Rate (Year over Year) 25.16% 23.17% 27.53% 24.17%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Celgene Has Loads of Potential Real Money Pro($)

This stock is poised for more upside.
It is hard to keep up with the flurry of first-quarter earnings reports hitting the wires this morning. Here are a few that caught my eye today.
As always, it is good to be sitting in for Doug Kass on the Daily Diary over the next two days. There is lots to talk about.
* Biotech (Allergan (AGN) , Celgene (CELG) and Gilead Sciences (GILD) ) * Speculative biotech ( ZIOPHARM Oncology (ZIOP) ,   SAGE Therapeutics (SAGE) , Intrexon (XON) , Valeant Pharmaceuticals (VRX) ,   ACADIA Pharmaceuticals (ACAD) , FibroGen  (FGEN) ). * DuPont (DD) , Netflix (NFLX) , Baidu (BIDU) , Radian (RDN) and Biogen   (BIIB) . * New tech - (T)FANG (TSLA) , (FB) , (AAPL) , (NFLX) , (GOOGL) . * Chipotle Mexican Grill (
'Til April in Paris, chestnuts in blossom Holiday tables under the trees April in Paris, this is a feeling That no one can ever reprise -

Intermediate Trade: Celgene Real Money Pro($)

I prefer a very short-term, out-of-the-money vertical call spread expiring in May.

Momentum Is Fading Real Money Pro($)

Forget financials, stick to steady growers.
So let's move to the abbreviated Monarch Notes form of "Takeaways," with "The Good, The Bad and The Ugly." The Good * Thus far, the "flight to safety" trades worked today - bonds, bond equivalent stocks, yen/dollar, gold. * The market brought in dip buyers -- though I am not sure it will last today. * Lumber +$10 - an outsized move. * Thus far, though down modestly, (T)FANG remains the place to be. * Seagate Technology (STX) and Western Digital (WDC) +. The Bad  
These stocks should be part of a strong first-quarter earnings season.

Takeaways And Observations Real Money Pro($)

For the first time in six years the DJIA fell for the eighth consecutive day. That said the Nasdaq has risen in ten of the last thirteen trading sessions as Donald Trump may be making volatility and uncertainty great again. (For that divergence and other reasons, in "Its All Relative" I like the long [SPDR S&P 500 ETF Trust] (SPY) /short [PowerShares QQQ Trust, Series 1 (ETF)] (QQQ) pairs trade). 

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.